SalemiVMC, MeloMDT, Araujo FilhoJAB. New Paradigms in the Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging in Aortic Valvopathy. Arq. Bras. Cardiol. 2020;114(2):293-4.
Salemi,Vera Maria Cury; Melo,Marcelo Dantas Tavares de; Araujo Filho,José de Arimatéia Batista. New Paradigms in the Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging in Aortic Valvopathy. Arq. Bras. Cardiol., v. 114, n. 2, p. 293-294, Feb. 2020.
Salemi,V.M.C., Melo,M.D.T. , & Araujo Filho,J.A.B. (2020). New Paradigms in the Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging in Aortic Valvopathy. Arq. Bras. Cardiol.,114(2), 293-294.
Salemi,Vera Maria Cury and Melo,Marcelo Dantas Tavares de and Araujo Filho,José de Arimatéia Batista. New Paradigms in the Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging in Aortic Valvopathy. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 2, [cited 2025-09-08], pp.293-294. Available from: <https://abccardiol.org/en/short-editorial/new-paradigms-in-the-evaluation-of-diastolic-function-by-cardiac-magnetic-resonance-imaging-in-aortic-valvopathy/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
